Unknown

Dataset Information

0

Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine.


ABSTRACT: Vaccination with different vaccines has been implemented globally to counter the continuous COVID-19 pandemic. However, the vaccine-elicited antibodies have reduced efficiency against the highly mutated Omicron sub-variants. Previously, we developed a protein subunit COVID-19 vaccine called ZF2001, based on the dimeric receptor-binding domain (RBD). This vaccine has been administered using different dosing intervals in real-world setting. Some individuals received three doses of ZF2001, with a one-month interval between each dose, due to urgent clinical requirements. Others had an extended dosing interval of up to five months between the second and third dose, a standard vaccination regimen for the protein subunit vaccine against hepatitis B. In this study, we profile B cell responses in individuals who received three doses of ZF2001, and compared those with long or short dosing intervals. We observed that the long-interval group exhibited higher and broader serologic antibody responses. These responses were associated with the increased size and evolution of vaccine-elicited B-cell receptor repertoires, characterized by the elevation of expanded clonotypes and somatic hypermutations. Both groups of individuals generated substantial amounts of broadly neutralizing antibodies (bnAbs) against various SARS-CoV-2 variants, including Omicron sub-variants such as XBB. These bnAbs target four antigenic sites within the RBD. To determine the vulnerable site of SARS-CoV-2, we employed cryo-electron microscopy to identify the epitopes of highly potent bnAbs that targeted two major sites. Our findings provide immunological insights into the B cell responses elicited by RBD-based vaccine, and suggest that a vaccination regimen of prolonging time interval should be used in practice.

SUBMITTER: Guo S 

PROVIDER: S-EPMC10382582 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine.

Guo Shuxin S   Zheng Yuxuan Y   Gao Zhengrong Z   Duan Minrun M   Liu Sheng S   Du Pan P   Xu XiaoYu X   Xu Kun K   Zhao Xin X   Chai Yan Y   Wang Peiyi P   Zhao Qi Q   Gao George F GF   Dai Lianpan L  

Cell discovery 20230728 1


Vaccination with different vaccines has been implemented globally to counter the continuous COVID-19 pandemic. However, the vaccine-elicited antibodies have reduced efficiency against the highly mutated Omicron sub-variants. Previously, we developed a protein subunit COVID-19 vaccine called ZF2001, based on the dimeric receptor-binding domain (RBD). This vaccine has been administered using different dosing intervals in real-world setting. Some individuals received three doses of ZF2001, with a o  ...[more]

Similar Datasets

| S-EPMC11249148 | biostudies-literature
| S-EPMC11313003 | biostudies-literature
| S-EPMC4497764 | biostudies-literature
| S-EPMC4465343 | biostudies-literature
| S-EPMC11345946 | biostudies-literature
| S-EPMC8960152 | biostudies-literature
| S-EPMC9734167 | biostudies-literature
| S-EPMC4970321 | biostudies-literature
| S-EPMC9282883 | biostudies-literature
| S-EPMC8894731 | biostudies-literature